Intervention Protocol

Luteinising hormone releasing hormone (LHRH) analogues for children or adolescents with early puberty, idiopathic short stature or growth hormone deficiency

  1. Angela M Spinola-Castro1,*,
  2. Humberto Saconato2,
  3. Adriana ASM Siviero-Miachon3

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 23 JAN 2008

Assessed as up-to-date: 13 NOV 2007

DOI: 10.1002/14651858.CD006970


How to Cite

Spinola-Castro AM, Saconato H, Siviero-Miachon AASM. Luteinising hormone releasing hormone (LHRH) analogues for children or adolescents with early puberty, idiopathic short stature or growth hormone deficiency (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD006970. DOI: 10.1002/14651858.CD006970.

Author Information

  1. 1

    Federal University of Sao Paulo, Sao Paulo, Brazil

  2. 2

    Federal University of Rio Grande do norte, Department of Medicine, São Paulo, Vila Clementino, Brazil

  3. 3

    Universidade Federal de São Paulo, Pediatrics, São Paulo, Brazil

*Angela M Spinola-Castro, Federal University of Sao Paulo, R.Pedro de Toledo 980-52, Sao Paulo, 04039002, Brazil. amsc@uol.com.br.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 JAN 2008

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of luteinising releasing hormone analogues for children and adolescents with early puberty, idiopathic short stature or growth hormone deficiency.